Table 2. Statistical performance characteristics of urinary biomarkers to differentiate PDAC from controls.
Biomarker | Sensitivity (%) | Specificity (%) | AUC | 95% CI |
---|---|---|---|---|
uMMP-2a | 70 | 85 | 0.784 | 0.701–0.870 |
uTIMP-1a | 90 | 70 | 0.803 | 0.723–0.883 |
uMMP-2a/uTIMP-1a | 91 | 75 | 0.861 | 0.790–0.937 |
Abbreviations: AUC=area under the curve; CI=confidence interval; PDAC=pancreatic ductal adenocarcinoma; ROC=receiver operating characteristic; uMMP-2=urinary matrix metalloprotease-2; uTIMP-1= urinary tissue inhibitor of metalloprotease-1.
Cutoff values for MMP-2 (>1.1 ng ml–1) and TIMP-1 (>0.9 ng ml–1) were identified using the Youden index in ROC analysis to compute sensitivity and specificity, respectively.